文献速递乳房整形与再造显微修复重建创面修复

辅助镇痛药物对腹部皮瓣乳房再造术后住院阿片类用药的影响

The Effects of Adjunctive Pain Medications on Postoperative Inpatient Opioid Use in Abdominally Based Microsurgical Breast Reconstruction.
PubMed 文献 · Ann Plast Surg · 2020-01-01

本研究回顾性分析328例腹部游离皮瓣乳房再造患者,量化术后住院阿片类用药量(口服吗啡当量,MME)并识别相关因素。双侧再造、手术时间延长、术前疼痛及术后初始疼痛评分>5/10与MME增加相关;静脉对乙酰氨基酚1000 mg和口服布洛芬600 mg可显著减少MME。

要点

  • 双侧再造较单侧术后MME更高(115.2 vs 89.0,P=0.015)。
  • 每增加1小时手术时间,术后MME增加9.4(P<0.01)。
  • 静脉对乙酰氨基酚1000 mg和口服布洛芬600 mg分别减少MME 11.7和8.3。

核心结论

  • 双侧再造和更长手术时间导致术后MME增加。
  • 术前无疼痛及术后初始疼痛控制良好者所需阿片类更少。
  • 静脉对乙酰氨基酚和口服布洛芬可显著降低术后MME。

研究设计与样本

  • 回顾性电子病历数据提取,地点为宾夕法尼亚大学,时间2016年11月至2018年10月。
  • 纳入标准为当前 Procedural Terminology 编码19364且仅接受传统术后恢复方案的患者。
  • 统计分析采用t检验和线性回归。

主要发现

  • 双侧患者平均使用115.2 MME(95%CI 103.4-127.0),单侧患者89.0 MME(95%CI 70.0-108.0;P=0.015)。
  • 放置腹部补片患者(n=249)需113.0 MME(95%CI 100.5-125.5),未放置者(n=79)需83.8 MME(95%CI 68.8-98.7;P=0.016)。
  • 每增加1小时手术时间,术后MME增加9.4(P<0.01)。
  • 术前疼痛评分>0/10者需141.1 MME(95%CI 102.7-179.7),评分=0/10者需100.3 MME(95%CI 90.2-110.4;P<0.01)。
  • 术后初始疼痛评分>5/10者需141.1 MME(95%CI 119.9-162.2),≤5/10者需89.2 MME(95%CI 78.6-99.8;P<0.01)。

关键数值与推荐

  • 静脉对乙酰氨基酚1000 mg剂量可使术后MME减少11.7(P=0.024)。
  • 口服布洛芬600 mg剂量可使术后MME减少8.3(P<0.01)。

临床怎么用

  • 对腹部皮瓣乳房再造患者,尤其是双侧再造或手术时间较长者,应预期更高阿片类需求并优化辅助镇痛。
  • 围术期可考虑规律使用静脉对乙酰氨基酚1000 mg和口服布洛芬600 mg以减少阿片类用量。
  • 关注术前存在疼痛及术后初始疼痛评分>5/10的患者,加强疼痛管理以降低阿片类消耗。

局限性

  • 本研究为单中心回顾性研究,仅纳入传统术后恢复方案患者,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purposes of this study were to quantify the amount of opioid medication used postoperatively in the hospital setting after abdominally based microsurgical breast reconstruction, to determine factors that are associated with increased opioid use, and to identify other adjunctive medications that may contribute to decreased opioid use. METHODS: An electronic medical record data pull was performed at the University of Pennsylvania from November 2016 to October 2018. Cases were identified using Current Procedural Terminology code 19364. Only traditional recovery after surgery protocol patients were included. Patient comorbidities, surgical details, and pain scores were captured. Postoperative medications including non-patient-controlled analgesia opioid use and adjunctive nonopioid pain medications were recorded. Non-patient-controlled analgesia total opioid use was calculated and converted to oral morphine milligram equivalents (mme). Statistical analysis was performed using t test analyses and linear regression. RESULTS: A total of 328 patients satisfied our inclusion criteria. Five hundred forty free flaps were performed (212 bilateral vs 116 unilateral, 239 immediate vs 89 delayed). Bilateral patients used on average 115.2 mme (95% confidence interval [CI], 103.4-127.0 mme) compared with 89.0 mme in unilateral patients (95% CI, 70.0-108.0 mme; P = 0.015). Patients with abdominal mesh placement (n = 249) required 113.0 mme (95% CI, 100.5-125.5 mme) compared with 83.8 mme (95% CI, 68.8-98.7 mme) for patients without mesh (n = 79; P = 0.016). Each additional hour of surgery increased postoperative mme by 9.4 (P < 0.01). Patients with a nonzero preoperative pain score required 100.3 mme (95% CI, 90.2-110.4 mme) compared with 141.1 mme (95% CI, 102.7-179.7 mme) for patients with preoperative pain score greater than 0/10 (P < 0.01). Patients with postoperative index pain score ≤5/10 required 89.2 mme (95% CI, 78.6-99.8 mme) compared with 141.1 mme (95% CI, 119.9-162.2 mme) for patients with postoperative index pain score >5/10 (P < 0.01). After regression analysis, a dose of intravenous acetaminophen 1000 mg was found to decrease postoperative mme by 11.7 (P = 0.024). A dose of oral ibuprofen 600 mg was found to decrease postoperative mme by 8.3 (P < 0.01). CONCLUSIONS: Bilateral reconstruction and longer surgery resulted in increased postoperative mme. Patients with no preoperative pain required less opioids than did patients with preexisting pain. Patients with good initial postoperative pain control required less opioids than did patients with poor initial postoperative pain control. Intravenous acetaminophen and oral ibuprofen were found to significantly decrease postoperative mme.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Yan C, Wink JD, Ligh CA, et al. The Effects of Adjunctive Pain Medications on Postoperative Inpatient Opioid Use in Abdominally Based Microsurgical Breast Reconstruction. Ann Plast Surg. 2020. PMID: 32028465. doi:10.1097/SAP.0000000000002249

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。